Large-scale testing (Phase 3)Study completedNCT04225156
What this trial is testing
A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).
Who this might be right for
Primary Immune Thrombocytopenia
argenx 101